Vagomimetic Effects of Fingolimod: Physiology and Clinical Implications

Fingolimod is a sphingosine 1‐phosphate (S1P) receptor modulator approved to treat relapsing‐remitting multiple sclerosis (MS). Initiation of treatment with fingolimod has been found to produce transient bradycardia and/or slowing of atrioventricular impulse conduction in a small proportion of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanoli, Emilio, Pentimalli, Francesco, Botto, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204275/
https://www.ncbi.nlm.nih.gov/pubmed/24836740
http://dx.doi.org/10.1111/cns.12283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204275/
https://www.ncbi.nlm.nih.gov/pubmed/24836740
http://dx.doi.org/10.1111/cns.12283

Ejemplares similares